Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kothekar

Showing results (101-110 of 261) with videos related to

Pageof 27
Sort By:
Journal of the American Academy of Dermatology|March 30, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b studyKurt Gebauer, Lynda Spelman, Paul S Yamauchi, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 23, 2020
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring systemEsha Kothekar, Mona-Elisabeth Revheim, Austin J Borja, et al.
Journal of the American Academy of Dermatology|December 26, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trialHoward L Sofen, Kurt Gebauer, Lynda Spelman, et al.
Annals of Intensive Care|January 12, 2020
Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteriaAmol T Kothekar, Jigeeshu Vasishtha Divatia, Sheila Nainan Myatra, et al.
Nuclear Medicine Communications|December 21, 2019
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodologyEsha Kothekar, Dani Yellanki, Austin J Borja, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|February 18, 2020
Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic UptakeChaitanya Rojulpote, Siavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Druggable genome CRISPRi screen in 3D hydrogels reveals regulators of cortactin-driven actin remodeling in invading glioblastoma cellsMufeng Hu, Anna Weldy, Isabella Lovalvo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2023
Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapyD Evanson, M Griffin, S E O'Reilly, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2020
Role of <sup>18</sup>F-NaF-PET in assessing aortic valve calcification with ageChaitanya Rojulpote, Austin J Borja, Vincent Zhang, et al.
Journal of Cancer Research and Clinical Oncology|April 20, 2018
A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastimCornelius F Waller, Renger G Tiessen, Tracey E Lawrence, et al.
Pageof 27

Showing results (101-110 of 261) with videos related to

Sort By:
Pageof 27
Journal of the American Academy of Dermatology|March 30, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b studyKurt Gebauer, Lynda Spelman, Paul S Yamauchi, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 23, 2020
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring systemEsha Kothekar, Mona-Elisabeth Revheim, Austin J Borja, et al.
Journal of the American Academy of Dermatology|December 26, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trialHoward L Sofen, Kurt Gebauer, Lynda Spelman, et al.
Annals of Intensive Care|January 12, 2020
Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteriaAmol T Kothekar, Jigeeshu Vasishtha Divatia, Sheila Nainan Myatra, et al.
Nuclear Medicine Communications|December 21, 2019
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodologyEsha Kothekar, Dani Yellanki, Austin J Borja, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|February 18, 2020
Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic UptakeChaitanya Rojulpote, Siavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Druggable genome CRISPRi screen in 3D hydrogels reveals regulators of cortactin-driven actin remodeling in invading glioblastoma cellsMufeng Hu, Anna Weldy, Isabella Lovalvo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2023
Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapyD Evanson, M Griffin, S E O'Reilly, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 27, 2020
Role of <sup>18</sup>F-NaF-PET in assessing aortic valve calcification with ageChaitanya Rojulpote, Austin J Borja, Vincent Zhang, et al.
Journal of Cancer Research and Clinical Oncology|April 20, 2018
A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastimCornelius F Waller, Renger G Tiessen, Tracey E Lawrence, et al.
Pageof 27